health & science
Can an immune system distracted by post-surgery healing allow previously dormant cancer cells to wake up and cause havoc? Scientists say the science isnt settled but old drugs may help.
For years theres been a question surrounding breast cancer surgery. Twelve to 18 months after surgery theres a high recurrence rate of cancer.
It was a dilemma put to the test in mice, the results suggestingthe bodys healing response to surgery could be the reason.
The hypothesis is while the body is busy healing a wound, the immune system is less able to keep cancer cells - which had already spread to other areas of the body - dormant.
Surprisingly, the study found giving the mice over-the-counter anti-inflammatory medicine before and after surgery could reduce the risk.
The study received a fair bit of attention. There was worry from some quarters it may lead to people rejecting important surgery. It also highlighted something as cheap as aspirin could improve patients outcomes.
According to University of Otago research fellow Dr Nicholas Fleming, surgery is almost always the best option.
His view is the science on surgery and cancer-spread isnot settled, and while there may be a risk, not having surgery creates a worse situation.
If you cut a cancer out early, hopefully you get all of the cancer and thats the end of it.
The later the surgery, the greater the chance the cancer has spread.
He describes the question of what causes cancer to spread as a million-dollar question. Heputs it down to a collection of mutations.
For the most part, cancer cells do one thing:life revolves around dividing.
But in the tumour some rebels emerge. Not content to simply divide, they leave home and roam the body. Eventually, these find new spots to colonise. In their new home they begin to divide once more, creating new tumours.
Thats why the most important thing in cancer treatment is treating people before they get to that point because after that it becomes very, very hard to save their lives.
Fleming has been looking at whether existing drugs thatare out of patent(and dirt cheap as a result)couldhelp fight cancer spread.
The idea of repurposing drugs is an area gaining traction. It was sparked by data showing diabetics taking metformin for their diabetes had a lower rate of cancer than those not taking it.
Since then, hundreds of drugs - not initially designed with cancer in mind - have been associated with effects on cancer.
Association isnt rock solid proof. The gold standard of proof comes from expensive clinical trials.
For old drugs with expired patents, this is an issue. Theres no financial incentive for drug companies to fund clinical trials of drugs they wont profit from.
As a publicly-funded researcher, Fleming is in a position to look at some of the off-patent drugs pharmaceutical companies arent interested in.
Rapamycin, used since the 1970s to stop transplants from being rejected, is one drug hes looked at. He describes it as anti-inflammatory and anti-migratory.
That drug can stop cells crawling. If you have cells that are migrating, you can stop them with that.
Fleming, who is also looking at pairing old drugs with the new immunotherapy drugs, is not the only scientist in New Zealand looking at repurposed drugs.
Gillies McIndoe Research Institute executive director Dr Swee Tans clinical trial is treating brain cancer with drugs thatcost $5 once every three months.
Its the worst brain cancer, its the most aggressive brain cancer. The median survival is that half the patients will die within 15 months after diagnosis. About half of them will recur within six months of treatment and once they have recurred, about half will die in six months.
He said 11 people currently in the trial wereliving longer than expected. The treatment uses blood pressure pills.
We say cancer is caused by stem cells that have misbehaved and caused cancer.
Tan uses the analogy of a beehive. A queen bee stem cell makes worker bees thatcreate the tumour, it also makes another queen bee thattravels elsewhere in the body and starts another hive.
He found the renin-angiotensin system, which regulates blood pressure and electrolyte balance, also controls the queen bee.
The implication is you might be able to design treatment to control cancer by controlling the cancer stem cells by using medications which control the renin-angiotensin system.
Delaying clinical proof is funding.
New Zealand spends $1 billion a year to treat cancer. That cost is escalating because of very expensive cancer drugs. If the government put aside 1 percent of that - $10 million a year to fund research like this - it will take this whole debate forward. It would allow the work to be done to prove it one way or the other.
Dr David Jennings, a Bay of Islands GP, thinks theres a case for not waiting for clinical trials.
As a GP hes seen the fireworks of cancer spread in patients. He also lost a close friend, and the process of trying to help turned him into an advocate for repurposed drugs.
His friends cancer had spread by the time it was diagnosed, but Jennings believes the repurposed drugs in conjunction with traditional cancer treatments extended his time, and improved its quality.
Lets say were losing 1000 patients a year, in 10 yearsthats 10,000 people. Thats a hell of a lot of people waiting for these studies to be done.
While clinical trials struggle to get funding, he thinks patients can take a lead, do research and talk to their GP. With repurposed drugs having been around for decades, side effects are well-known.
Were in a good position in New Zealand in terms of being able to repurpose drugs, but it will have to be a patient and doctor decision.
Off-label and untapped - are old drugs new cancer treatments?
- Stem Cell Transplants Used to Grow Fully Functional Lungs in Mice - Technology Networks - November 11th, 2019
- Human Heart Cells Transform in Space; Return to Normal on Earth: Study - The Weather Channel - November 11th, 2019
- Serving those who serve us - The Hub at Johns Hopkins - November 11th, 2019
- Kadimastem to Present Interim Results of Cohort A of Its Phase 1/2a Clinical Trial in ALS at the 7th International Stem Cell Meeting, in Tel-Aviv,... - November 11th, 2019
- The Value and Versatility of Clinical Flow Cytometry - Technology Networks - November 11th, 2019
- Global Cell Harvesting Industry Research: Key Companies Profile with Sales, Revenue, Market Share, Price and Competitive Situation Analysis - Inquiry... - November 11th, 2019
- Human heart cells are altered by spaceflight, but return mostly to normal on Earth - Space Daily - November 9th, 2019
- Jennifer OConnell: President Kanye in 2024? Be very afraid America - The Irish Times - November 9th, 2019
- Cord Blood Stem Cells Market Executive Summary, Introduction, Sizing, Analysis and Forecast To 2025 - Markets Gazette 24 - November 9th, 2019
- Global Animal Stem Cell Therapy Market - Industry Outlook and Forecast 2019-2024 - Real Viewpoint - November 9th, 2019
- Novel Molecule Reduces the Aggressiveness of Pediatric Cancer - Technology Networks - November 7th, 2019
- 2019s Allen Distinguished Investigators will focus on the mysteries of our cells - Yahoo Tech - November 7th, 2019
- At the American Academy of Stem Cell Physicians Live Congress 2019, FDA Safety Panel Says No to the Bad Actors - PRNewswire - November 7th, 2019
- MD Anderson Partners with Takeda to Develop CAR Natural Killer-Cell Therapy - Cancer Network - November 7th, 2019
- First UK patient treated with tissue engineered product for rare eye disease - Hospital Healthcare Europe - November 7th, 2019
- Spaceflight alters heart cells but they quickly recover back on Earth - New Scientist News - November 7th, 2019
- Stem Cell Assay Market To Witness Increase In Revenues By 2024 - Montana Ledger - November 7th, 2019
- Researchers Find Link Between Eye Disease And Degeneration Of The Brain - BioSpace - November 7th, 2019
- Physicians' Education Resource to Host Satellite Symposia at Annual American Society of Hematology Meeting and Exposition in Orlando - Business Wire - November 7th, 2019
- Keep Bioethics out of Elementary and High Schools - National Review - November 7th, 2019
- Stem Cell Cartilage Regeneration Market 2019, Trend, CAGR Status, Growth, Analysis and Forecast to 2025 - Virtualnewsusa - November 7th, 2019
- The Bold and the Beautiful Star Don Diamont Supports ALS Research - Soap Hub - November 7th, 2019
- International Conference on Stem Cells and Regenerative Medicine - Hoover Sun - November 5th, 2019
- Global Cancer Stem Cell Market Forecast to 2024 by Types, Application and by Regions - Exchange 99 - November 5th, 2019
- Lymphatic System Discovered To Play Key Role in Hair Regeneration - Technology Networks - November 5th, 2019
- Stem cell transplants approved for people with MS in Scotland - MS Trust - November 5th, 2019
- Johns Hopkins professor to lecture on interplay of secular bioethics, religion as part of Honors Colloquium - URI Today - November 5th, 2019
- Russell Brand Defends Lewis Hamiltons Vegan Hypocrisy and It Will Make You Think - LIVEKINDLY - November 5th, 2019
- Latest Report on Stem Cell Banking Market to Drive Amazing Growth by 2025 | Cord Blood Registry (CBR) Systems - News Hours Today - November 5th, 2019
- Global Stem Cell Cartilage Regeneration Market 2019, Trend, CAGR Status, Growth, Analysis and Forecast to 2024 - BeetleVersion - November 5th, 2019
- The House of Lords is needed to protect democracy now more than ever - The Independent - November 3rd, 2019
- Late-Term Abortion and an Election in Virginia - Newsmax - October 31st, 2019
- AIVITA Biomedical Announces Publication Detailing Immune Mechanisms Leading to Complete Remission of Measurable Metastatic Melanoma in Patient Treated... - October 31st, 2019
- CHS teacher enjoys prepping students for life out on their own - Albuquerque Journal - October 31st, 2019
- bluebird bio Reports Third Quarter 2019 Financial Results and Highlights Operational Progress - Business Wire - October 31st, 2019
- Global Cell Culture Protein Surface Coating Market: What it got next? Find out with the latest research available at 'The Market Reports' - Market... - October 31st, 2019
- SCD, HIV Gene Therapy Efforts Get $200M from NIH, Gates Foundation - Sickle Cell Anemia News - October 31st, 2019
- Global 3D Cell Culture Markets, 2019-2025: Cancer & Stem Cell Research Displays the Potential to Grow at Over 21.9% - ResearchAndMarkets.com -... - October 26th, 2019
- UCI IN THE NEWS OCT. 25, 2019 - UCI News - October 26th, 2019
- Mini-brains may already be sentient and suffering, scientists warn - Big Think - October 26th, 2019
- UK and China scientists developing new drugs to fight Tuberculosis - University of Birmingham - October 26th, 2019
- Global Stem Cell Therapy Market Global and Regional Analysis by Top Key Market Players, Key Regions, Product Segments, and Applications 2024 - Globe... - October 24th, 2019
- Do transhumanists need their own bill of rights? - Quartz - October 22nd, 2019
- Global Wound Care Market Outlook to 2024: New Product Approvals/Launches, Emergence of Stem Cell Therapy For Wound Healing - P&T Community - October 22nd, 2019
- New study reveals why breast cancer spreads to the brain - USC News - October 22nd, 2019
- Meet the axolotl: A cannibalistic salamander that regenerates its limbs and might help us better understand human stem cell therapy -... - October 22nd, 2019
- More awareness needed on stem cell donation: expert - The Hindu - October 22nd, 2019
- Lucknow: In a first, 26-yr-old DMD patient in UP survives with stem cell therapy - ETHealthworld.com - October 22nd, 2019
- Registration Open for The Eye and The Chip Research Congress - Newswise - October 22nd, 2019
- Cesca Therapeutics Forms Joint Venture with Healthbanks Biotech (USA) to Provide Immune Cell Banking and Cell Processing Services - P&T Community - October 22nd, 2019
- 'I've potentially saved a stranger's life by donating my blood stem cells and it was painless' - inews - October 22nd, 2019
- CST and Cell Press launch Cell Mentor in China - BSA bureau - October 22nd, 2019
- How stem cells are helping to mend broken hearts - Belfast Telegraph - October 22nd, 2019
- Iran sends US list of names for its proposed prisoner swap - Stars and Stripes - October 22nd, 2019
- Multiple Myeloma Experts, Patients, Advocates and Caregivers Team Up to Hike Through Patagonia - BioSpace - October 22nd, 2019
- Analysis Determines Cost Effectiveness of Various Treatment Strategies for Multiple Myeloma - Cancer Therapy Advisor - October 11th, 2019
- Stem cell therapy helped Owen Franks but there's still plenty to prove - Stuff.co.nz - October 11th, 2019
- AgeX Therapeutics to Present at Metabesity 2019 - Business Wire - October 11th, 2019
- Stem Cell Characterization Kits Market 08-Year Market Forecast and Trends Analysis Research Report - The Tribune City - October 10th, 2019
- New Cambridge research could lead to novel cancer therapies - Business Weekly - October 10th, 2019
- Global 3D Bioprinting Market Outlook, 2019-2024 - Market Anticipated to Reach $1.64 Billion by 2024 - ResearchAndMarkets.com - Business Wire - October 10th, 2019
- Stem Cell Cartilage Regeneration Market 2019: Prosperous Growth, Recent Trends and Demand by Top Key Vendors like Anika Therapeutics, Biomet,... - October 10th, 2019
- Industry Champion Jim Greenwood to Retire Following 2020 Elections - BioSpace - October 10th, 2019
- Cell Culture Protein Surface Coatings Market will Going to be Worth US$ 623.4 Mn by 2020 - Online News Guru - October 10th, 2019
- NIH funding bolsters rare diseases research collaborations | National Institutes of Health - National Institutes of Health - October 4th, 2019
- Stem Cell Therapy Market worth USD 4759.27 Million By 2024 - Global Market News 24 - October 4th, 2019
- Genome editing to be tested in kidney organoids - UW Medicine Newsroom - October 2nd, 2019
- First Patient Enrolled in Novel Stem Cell Trial for Heart Failure Treatment - Newswise - October 2nd, 2019
- Vor Biopharma Hires Senior Cell and Gene Therapy Leaders as Chief Technology Officer and Vice President of Research - Business Wire - October 2nd, 2019
- Now in development: off-the-shelf stem cells - Knowable Magazine - September 28th, 2019
- Immunity Against Cancer? Engineered Killer T Cells May Be the Key. - SciTechDaily - September 28th, 2019
- 'Provocative' Results With Stem Cells in Progressive MS - Medscape - September 27th, 2019
- 'I've Been Duped': Disabled Veteran Says He Spent Thousands at Health Center With No Improvement - NBC Bay Area - September 27th, 2019
- Finding alternatives to animal testing - University of California - September 27th, 2019
- Gene therapy shows promise repairing brain tissue damaged by stroke - National Institute on Aging - September 27th, 2019
- Vitro Biopharma 3rd Quarter ended July 31st 2019 Financial Results of Operations - Yahoo Finance - September 27th, 2019
- Science Talk - Celebrating Professor Sir Mel Greaves and his legacy in leukaemia research - The Institute of Cancer Research - September 27th, 2019
- New restrictions put fetal tissue research in the balance - AAMCNews - September 25th, 2019
- 'I've Been Duped': Disabled Veteran Says He Spent Thousands at Health Center With No Improvement - NBC Southern California - September 25th, 2019
- New Research Suggests a Cure for HIV Could be on the Horizon - BioSpace - September 25th, 2019